Skip to main content
SpringerLink
Log in

AIDS and Acute Kidney Failure

  • Chapter
  • First Online:
Management of Acute Kidney Problems

  • 2471 Accesses

Abstract

HIV-infected patients may present with a variety of patterns of renal involvement Acute kidney failure (AKF) is common and is often the result of acute tubular necrosis (ATN), acute interstitial nephritis, and thrombotic microangiopathy The most common precipitating factors of ATN include medications and dehydration superimposed on sepsis, hypotension, and respiratory failure It is potentially avoidable, and support through the period of renal failure may lead to resolution of the renal dysfunction Although it is potentially reversible with dialysis support, AKF nonetheless carries a high mortality

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lameire N, Van BW, Vanholder R: Acute renal failure. Lancet 2005; 365: 417 –430.

    CAS  PubMed  Google Scholar 

  2. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996; 50: 811–818.

    Article  CAS  PubMed  Google Scholar 

  3. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139:214–226.

    CAS  PubMed  Google Scholar 

  4. Perazella MA. Acute renal failure in HIV-infected patients: a brief review of common causes. Am J Med Sci 2000; 319:385–391.

    Article  CAS  PubMed  Google Scholar 

  5. Peraldi MN, Maslo C, Akposso K, Mougenot B, Rondeau E, Sraer JD. Acute renal failure in the course of HIV infection: a single institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant 1999; 14:1578–1585.

    Article  CAS  PubMed  Google Scholar 

  6. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005;40:559–1585.

    Article  PubMed  Google Scholar 

  7. Wyatt CM, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 20:561–565.

    Article  PubMed  Google Scholar 

  8. Rao TKS, Friedman EA. Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 1995; 25:390–398.

    Article  CAS  PubMed  Google Scholar 

  9. Lopes JA, Fernandes J, Jorge S, Neves J, Antunes F, Prata MM. An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients. Crit Care 2007; 11:401.

    Article  PubMed  Google Scholar 

  10. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:429–434.

    CAS  PubMed  Google Scholar 

  11. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 2005; 16:2412–2420.

    Article  CAS  PubMed  Google Scholar 

  12. Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987–1999. J Acquir Immune Defic Syndr 2002; 29: 378–387.

    PubMed  Google Scholar 

  13. Franceschini N, Napravnik S, Eron JJ Jr, Szczech LA, Finn WF. Incidence and etiology of acute renal failure among ambulatory HIVinfected patients. Kidney Int 2005; 67: 1526–1531.

    Article  PubMed  Google Scholar 

  14. Spichler A., Andrade L., Seguro A.C. Acute renal failure in HIV patients in intensive care. 9th European AIDS Conference (EACS) 1st EACS Resistance & Pharmacology Workshop. October 25–29, 2003 Warsaw, Poland.

    Google Scholar 

  15. Roe J, Campbell LJ, Ibrahim F, Hendry BM, Post FA. HIV care and the incidence of acute renal failure. Clin Infect Dis 2008; 47:242–249.

    Article  PubMed  Google Scholar 

  16. Sherman KE, Rouster SD, Chung RT, Rajicic N: Hepatitis C virus prevalence among patients infected with human ­immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831–837.

    Article  PubMed  Google Scholar 

  17. Blaas S, Schneidewind A, Gluck T, Salzberger B. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases. AIDS 2006; 20: 1786–1787.

    Article  PubMed  Google Scholar 

  18. Mehta RL, Pascual MT, Gruta CG, Zhuang S, Chertow GM. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13:1350–1357.

    Article  PubMed  Google Scholar 

  19. Rao TK, Friedman EA. Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 1995; 25:390–398.

    Article  CAS  PubMed  Google Scholar 

  20. Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V. The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 1988; 12: 131–137.

    CAS  PubMed  Google Scholar 

  21. Naicker S, Aboud O, Gharbi MB. Epidemiology of acute kidney injury in Africa. Semin Nephrol 2008; 28:348–353.

    Article  PubMed  Google Scholar 

  22. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316:1062–1068.

    Article  CAS  PubMed  Google Scholar 

  23. Valeri A, Neusy AJ. Acute and chronic renal disease in hospitalized AIDS patients. Clin Nephrol 1991; 35:110–118.

    CAS  PubMed  Google Scholar 

  24. Williams DI, Williams DJ, Williams IG, Unwin RJ, Griffiths MH, Miller RF. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm Infect 1998; 74:179–184.

    Article  CAS  PubMed  Google Scholar 

  25. Perazella MA. Acute renal failure in HIV-infected patients: a brief review of common causes. Am J Med Sci 2000; 319:385–391.

    Article  CAS  PubMed  Google Scholar 

  26. Cohen SD, Chawla LS, Kimmel PL. Acute kidney injury in patients with human immunodeficiency virus infection. Curr Opin Crit Care 2008; 14:647–653.

    Article  PubMed  Google Scholar 

  27. Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003; 63:1618–1631.

    Article  PubMed  Google Scholar 

  28. Pannu N, Wiebe NM, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295:2765–2779.

    Article  CAS  PubMed  Google Scholar 

  29. Moriyama Y, Minamidate Y, Yasuda M, Ehara H, Kikuchi M, Tsuchiya T, Deguchi T, Tsurumi H. Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient. Urol Res 2008; 36:275–277.

    Article  PubMed  Google Scholar 

  30. Kennedy WA II, Benson MC, Kaplan SA. Urologic manifestations of HIV infection. In: Kimmel PL, Berns JS, J Stein, eds. Renal and urologic complications of HIV infection. Contemporary issues in nephrology. New York: Churchill Livingstone; 1995. pp. 181–193.

    Google Scholar 

  31. Jehle AW, Khanna N, Sigle JP, Glatz-Krieger K, Battegay M, Steiger J, Dickenmann M, Hirsch HH. Acute renal failure on immune reconstitution in an HIV-positive patient with miliary tuberculosis. Clin Infect Dis 2004; 38: 32–35.

    Article  Google Scholar 

  32. Daugas E, Plaisier E, Boffa JJ, Guiard-Schmid JB, Pacanowski J, Mougenot B, Ronco P. Acute renal failure associated with immune restoration inflammatory syndrome. Nat Clin Pract Nephrol 2006; 2: 594–598;

    Article  PubMed  Google Scholar 

  33. Izzedine H, Brocheriou I, Martinez V, Deray G. IRIS and acute granulomatous interstitial nephritis. AIDS 2007; 21:534–535.

    Article  PubMed  Google Scholar 

  34. Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, Solomon GE, Winchester R. A diffuse infil­trative CD8 lymphocytosis syndrome in human immuno­deficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990; 112:3–10.

    CAS  PubMed  Google Scholar 

  35. Basu D, Williams FM, Ahn CW, Reveille JD. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 2006; 55: 466–472.

    Article  PubMed  Google Scholar 

  36. Zafrani L, Coppo P, Dettwiler S, Molinier-Frenkel V, Agbalika F, Guiard-Schmid JB, Pialoux G, Xu-Dubois YC, Rondeau E, Hertig A.Nephropathy associated with the diffuse infiltrative lymphocytosis syndrome. Kidney Int 2007; 72:219–224.

    Article  CAS  PubMed  Google Scholar 

  37. Izzedine H, Brocheriou I, Valantin MA, Camous L, Bourry E, Baumelou A, Deray G, Katlama C. A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome. Nat Clin Pract Nephrol 2008; 4:110–114.

    Article  PubMed  Google Scholar 

  38. Meisenberg BR, Robinson WL, Mosley CA, Duke MS, Rabetoy GM, Kosty MP. Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males. Am J Hematol 1988; 27:212–215.

    Article  CAS  PubMed  Google Scholar 

  39. Novitzky N, Thomson J, Abrahams L, du Toit C, McDonald A. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy. Br J Haematol 2005; 128:373–129.

    Article  PubMed  Google Scholar 

  40. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80:1890–1895.

    CAS  PubMed  Google Scholar 

  41. Maslo C, Buré-Rossier A, Girard PM, Gholizadeh Y, Lebrette MG, Rozenbaum W. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection. Clin Infect Dis 1997; 24:344–349.

    CAS  PubMed  Google Scholar 

  42. Sahud MA, Claster S, Liu L, Ero M, Harris K, Furlan M. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol 2002; 116:909–911.

    Article  CAS  PubMed  Google Scholar 

  43. Gunther K, Garizio D, Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion 2007; 47:1710–1716.

    Article  PubMed  Google Scholar 

  44. Savige JA, Chang L, Horn S, Crowe SM. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994; 18:205–211.

    Article  CAS  PubMed  Google Scholar 

  45. Szczech LA, Anderson A, Ramers C, Engeman J, Ellis M, Butterly D, Howell DN. The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. Am J Kidney Dis 2006; 48:e55–59.

    Article  PubMed  Google Scholar 

  46. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66:1145–1152.

    Article  PubMed  Google Scholar 

  47. Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 1999;246:247–252.

    Article  CAS  PubMed  Google Scholar 

  48. Ducharme MP, Smythe M, Strohs G. Drug-induced alterations in serum creatinine concentrations. Ann Pharmacother 1993; 27:622–633.

    CAS  PubMed  Google Scholar 

  49. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIV-associated renal diseases and highly active ­antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42:1488–1495.

    Article  CAS  PubMed  Google Scholar 

  50. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005; 45:804–817.

    Article  CAS  PubMed  Google Scholar 

  51. Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, Launay-Vacher V, Deray G. Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 2004; 18:1074–1076.

    Article  CAS  PubMed  Google Scholar 

  52. Perazella M. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003; 325:349–362.

    Article  PubMed  Google Scholar 

  53. Chariot P, Ruet E, Authier FJ, Lévy Y, Gherardi R. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 1994; 44:1692–1696.

    CAS  PubMed  Google Scholar 

  54. Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 1991; 29:606–614.

    Article  CAS  PubMed  Google Scholar 

  55. Chuck SK, Penzak SR. Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidemia. Expert Opin Drug Saf 2002; 1:5–17.

    Article  CAS  PubMed  Google Scholar 

  56. Fontaine C, Guaird-Schmid JB, Slama L, et al. Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate. AIDS 2005; 19:1927–1928.

    Article  PubMed  Google Scholar 

  57. Kopp JB, Miller KD, Mican JA, Feuerstein IM, Vaughan E, Baker C, Pannell LK, Falloon J. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997; 127:119–125.

    CAS  PubMed  Google Scholar 

  58. Reilly RF, Tray K, Perazella MA. Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors. Am J Kidney Dis 2001; 38:E23.

    Article  CAS  PubMed  Google Scholar 

  59. Dieleman JP, van Rossum AM, Stricker BC, Sturkenboom MC, de Groot R, Telgt D, Blok WL, Burger DM, Blijenberg BG, Zietse R, Gyssens IC. Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir. J Acquir Immune Defic Syndr 2003; 32:135–142.

    CAS  PubMed  Google Scholar 

  60. Brodie SB, Keller MJ, Ewenstein BM, Sax PE. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. AIDS 1998; 12:2433–2437.

    Article  CAS  PubMed  Google Scholar 

  61. Malavaud B, Dinh B, Bonnet E, Izopet J, Payen JL, Marchou B. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection. Antivir Ther 2000; 5:3–5.

    CAS  PubMed  Google Scholar 

  62. Squires K, Pozniak AL, Pierone G Jr, et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Ann Intern Med 2003; 139:313–320.

    CAS  PubMed  Google Scholar 

  63. Izzedine H, Hulot JS, Vittecoq D, Gallant JE, Staszewski S, Launay-Vacher V, Cheng A, Deray G; Study 903 Team. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 2005; 20: 743–746.

    Article  CAS  PubMed  Google Scholar 

  64. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with ténofovir is associated with mild renal dysfunction. AIDS 2005; 19:93–95.

    Article  CAS  PubMed  Google Scholar 

  65. Gallant JE, Parish MA, Keruly JC, Moore RD. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-­transcriptase inhibitor treatment. Clin Infect Dis 2005;40: 1194–1198.

    Article  CAS  PubMed  Google Scholar 

  66. Buchacz K, Young B, Baker RK, Moorman A, Chmiel JS, Wood KC, Brooks JT; the HIV Outpatient Study (HOPS) Investigators. Renal function in patients receiving Tenofovir with Ritonavir/Lopinavir or Ritonavir/Atazanavir in the HIV Outpatient Study (HOPS) Cohort. J Acquir Immune Defic Syndr 2006; 43: 626–628.

    Article  PubMed  Google Scholar 

  67. Goicoechea M, Liu S, Best B, et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus non nucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis 2008; 197:102–108.

    Article  CAS  PubMed  Google Scholar 

  68. Izzedine H, Launay-Vacher V, Deray G. Renal tubular transporters and antiviral drugs: an update. AIDS 2005; 19: 455–462.

    Article  CAS  PubMed  Google Scholar 

  69. Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 2006; 42:283–290.

    Article  CAS  PubMed  Google Scholar 

  70. Winston A, Amin J, Mallon P, Marriott D, Carr A, Cooper DA, Emery S. Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy. HIV Med. 2006; 7:105–111.

    Article  CAS  PubMed  Google Scholar 

  71. Ray AS, Cihlar T, Robinson KL, Tong L, Vela JE, Fuller MD, Wieman LM, Eisenberg EJ, Rhodes GR. Mechanism of active renal tubular efflux of tenofovir. Antimicrob Agents Chemother 2006; 50:3297–304.

    Article  CAS  PubMed  Google Scholar 

  72. Jullien V, Tréluyer JM, Rey E, Jaffray P, Krivine A, Moachon L, Lillo-Le Louet A, Lescoat A, Dupin N, Salmon D, Pons G, Urien S. Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy. Antimicrob Agents Chemother 2005; 49:3361–3366.

    Article  CAS  PubMed  Google Scholar 

  73. Kiser JJ, Carten ML, Aquilante CL, Anderson PL, Wolfe P, King TM, Delahunty T, Bushman LR, Fletcher CV. The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients. Clin Pharmacol Ther 2008; 83:265–272.

    Article  CAS  PubMed  Google Scholar 

  74. Côté HC, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, Yu E, Yip B, Zalunardo N, Werb R, Hogg R, Harrigan PR, Montaner JS. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther 2006; 11:79–86.

    PubMed  Google Scholar 

  75. Izzedine H, Hulot JS, Vittecoq D, Gallant JE, Staszewski S, Launay-Vacher V, Cheng A, Deray G; Study 903 Team. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 2005; 20:743–746.

    Article  CAS  PubMed  Google Scholar 

  76. Izzedine H, Hulot JS, Villard E, Goyenvalle C, Dominguez S, Ghosn J, Valantin MA, Lechat P, Deray AG. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis 2006; 194: 1481–1491.

    Article  CAS  PubMed  Google Scholar 

  77. Kiser JJ, Aquilante CL, Anderson PL, King TM, Carten ML, Fletcher CV. Clinical and genetic determinants of intra­cellular tenofovir diphosphate concentrations in HIV-infected patients. J Acquir Immune Defic Syndr 2008; 47:298–303.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, La Pitié-Salpêtrière Hospital, 47-80 Boulevard de l’Hôpital, Assistance Publique-Hopitaux de Paris, Pierre et Marie Curie University, 75013, Paris, France

    Hassane Izzedine

Authors
  1. Hassane Izzedine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hassane Izzedine .

Editor information

Editors and Affiliations

  1. Charité Campus Virchow, Universitätsklinikum Berlin, Augustenburger Platz 1, Berlin, 13353, Germany

    Achim Jörres

  2. Dipto. Nefrologia, Ospedale San Bortolo, Viale Rodolfi 16, Vicenza, 36100, Italy

    Claudio Ronco

  3. School of Medicine, University of Pittsburgh, Terrace Street 3550, Pittsburgh, 15261, U.S.A.

    John A. Kellum

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Izzedine, H. (2010). AIDS and Acute Kidney Failure. In: Jörres, A., Ronco, C., Kellum, J. (eds) Management of Acute Kidney Problems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69441-0_40

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69413-7

  • Online ISBN: 978-3-540-69441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation